Dr. Brian S. Metzger, MD

Dr. Metzger practices at Peterson Regional Medical Center in Kerrville, Texas, part of Peterson Health.

Dr. Metzger's NPI, 1538306899, was assigned on January 8, 2009. Dr. Metzger graduated from Medical College of Georgia in 2003. Dr. Metzger holds Texas license N2660.

Dr. Metzger's primary practice is Peterson Regional Medical Center, at 551 Hill Country Drive, Kerrville, TX 78028 in Kerr County. The practice phone is (830) 896-4200.

Dr. Metzger's primary practice is Peterson Regional Medical Center in Kerrville, Texas, part of Peterson Health. Dr. Metzger is also affiliated with St. David's Medical Center. The medical group on file is Austin Infectious Disease Consultants. Dmand AI also links Dr. Metzger to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Metzger practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Metzger's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Metzger is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Metzger's licenses on file in 2 states: Texas and New York.

Dmand AI lists cold sores or genital herpes, endocarditis, facial skin infection, hiv/aids and joint or bone infection among the conditions Dr. Metzger treats.

CMS data shows 545 Medicare services from Dr. Metzger across 7 procedure codes in 2024, for 169 Medicare patients. Medicare paid $45,537 for them.

CMS counts 169 Medicare patients who saw Dr. Metzger in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Metzger's median patient age at 66, with 41% women.

In 2024, Dr. Metzger wrote 421 Medicare Part D claims for 77 patients. 67% of them were for generic drugs. CMS names the drug for 316 of them, across 13 drugs with 11 or more claims each, at $424,767 in total drug cost. In 2023, CMS named 327 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Metzger for performance year 2024, reported as part of a group. Dr. Metzger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Metzger as offering telehealth.

Dmand AI links Dr. Metzger to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include COVID-19, Staphylococcal Infections and Gram-Positive Bacterial Infections.

CMS Open Payments shows 1,077 general payments to Dr. Metzger from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Allergan Inc. paid the most, $60,052.

Dr. Metzger graduated from Medical College of Georgia in 2003. Dr. Metzger is a member of IDSA and The Society for Healthcare Epidemiology of America.

Dr. Metzger is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.